Главная О нас Услуги Контакты
 

Valuation Gap

Valuation Gap

Capital‑market sentiment reflects this strategic focus. Bank of America reaffirmed a Sell rating with a $15 price target, citing a 49 % downside from current levels. Despite a 24 % decline in total shareholder return, the three‑year return has more than doubled, and analysts maintain an intrinsic value of $132.02 per share against a market price of $29.27. A Discounted Cash Flow model gives a bull‑case fair value of $44.43 and a bear‑case of $15.49, with a P/E of 9.67—well below the industry average of 20.98 and peer average of 60.21. The share price sits about 77.8 % below the DCF estimate and 34 % below analyst expectations, underscoring a wide valuation gap.
10/03/2026 | TG Therapeutics, Inc.